Epilepsy and Behavior Reports

1.1(top 50%)

impact factor

338(top 50%)

papers

761(top 50%)

citations

11(top 50%)

h-index

1.2(top 50%)

extended IF

348

all documents

948

doc citations

15(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Changing the culture of care for children and adolescents with functional neurological disorder	Epilepsy and Behavior Reports	2021	30
2	Making the switch: From case studies to N-of-1 trials	Epilepsy and Behavior Reports	2019	24
3	Treatment of vagus nerve stimulator-induced sleep-disordered breathing: A case series	Epilepsy and Behavior Reports	2019	21
4	Overlapping demyelinating syndrome and anti-N-methyl-d-aspartate receptor encephalitis with seizures	Epilepsy and Behavior Reports	2019	20
5	Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis	Epilepsy and Behavior Reports	2019	16
6	Resolution of cryptogenic new onset refractory status epilepticus with tocilizumab	Epilepsy and Behavior Reports	2021	16
7	Super refractory status epilepticus secondary to anti-GAD antibody encephalitis successfully treated with aggressive immunotherapy	Epilepsy and Behavior Reports	2020	15
8	Infantile spasms: Etiology, lead time and treatment response in a resource limited setting	Epilepsy and Behavior Reports	2020	14
9	Using evidence-based psychotherapy to tailor treatment for patients with functional neurological disorders	Epilepsy and Behavior Reports	2021	14
10	Reversible male infertility with valproate use: A review of the literature	Epilepsy and Behavior Reports	2021	14
11	Effects of anterior thalamic nuclei stimulation on hippocampal activity: Chronic recording in a patient with drug-resistant focal epilepsy	Epilepsy and Behavior Reports	2021	13
12	Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy	Epilepsy and Behavior Reports	2021	13
13	A historical review of functional neurological disorder and comparison to contemporary models	Epilepsy and Behavior Reports	2021	13
14	Identifying and evaluating novel treatment targets for the development of evidence-based interventions for functional neurological disorder	Epilepsy and Behavior Reports	2021	12
15	The IDH1 inhibitor ivosidenib improved seizures in a patient with drug-resistant epilepsy from IDH1 mutant oligodendroglioma	Epilepsy and Behavior Reports	2022	12
16	Teleneurology based management of infantile spasms during COVID-19 pandemic: A consensus report by the South Asia Allied West syndrome research group	Epilepsy and Behavior Reports	2021	10
17	Knowledge of Epilepsy and seizure first aid among teachers in Jeddah, Saudi Arabia	Epilepsy and Behavior Reports	2021	10
18	Neuroinflammation as a pathophysiological factor in the development and maintenance of functional seizures: A hypothesis	Epilepsy and Behavior Reports	2021	10
19	The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters	Epilepsy and Behavior Reports	2023	10
20	Resolution of EEG findings and clinical improvement in a patient with encephalopathy and ESES with a combination of immunomodulating agents other than corticosteroids: A case report	Epilepsy and Behavior Reports	2020	9
21	Remote delivery of cognitive behavioral therapy to patients with functional neurological disorders: Promise and challenges	Epilepsy and Behavior Reports	2021	9
22	Knowledge of and attitude towards epilepsy among university students in Saudi Arabia: Misconceptions of the next generation	Epilepsy and Behavior Reports	2021	9
23	Seizure control after late introduction of anakinra in a patient with adult onset Rasmussen’s encephalitis	Epilepsy and Behavior Reports	2021	9
24	One-year follow-up of treatment outcomes and patient opinions of Retraining and Control Therapy (ReACT) for pediatric functional seizures	Epilepsy and Behavior Reports	2021	9
25	Fighting autoinflammation in FIRES: The role of interleukins and early immunomodulation	Epilepsy and Behavior Reports	2022	9
26	Posterior-onset Rasmussen's encephalitis with ipsilateral cerebellar atrophy and uveitis resistant to rituximab	Epilepsy and Behavior Reports	2020	8
27	Acute modulation of the limbic network with low and high-frequency stimulation of the human fornix	Epilepsy and Behavior Reports	2020	8
28	Impact of epilepsy training on school teachers and counselors: An intervention study in Lebanon	Epilepsy and Behavior Reports	2020	8
29	Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up	Epilepsy and Behavior Reports	2021	8
30	A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy	Epilepsy and Behavior Reports	2019	7
31	Efficacy and tolerability of perampanel in patients with genetic generalized epilepsy (GGE): A retrospective, single-center study from the United Arab Emirates (UAE)	Epilepsy and Behavior Reports	2019	7
32	Long-term seizure freedom following intracranial sEEG monitoring: Therapeutic benefit of a diagnostic technique	Epilepsy and Behavior Reports	2019	7
33	Focal seizures associated with the chapeau de gendarme sign or ictal pouting of insular origin	Epilepsy and Behavior Reports	2019	7
34	Variable treatment response in a patient with pyridoxal N phosphate oxidase (PNPO) deficiency- understanding the paradox	Epilepsy and Behavior Reports	2020	7
35	The unmet need for rapid epileptic seizure termination (REST)	Epilepsy and Behavior Reports	2021	7
36	A presumed case of new-onset focal seizures as a delayed complication of COVID-19 infection	Epilepsy and Behavior Reports	2021	7
37	Improving public stigma, sociocultural beliefs, and social identity for people with epilepsy in the Aseer region of Saudi Arabia	Epilepsy and Behavior Reports	2021	7
38	A de novo heterozygous rare variant in SV2A causes epilepsy and levetiracetam-induced drug-resistant status epilepticus	Epilepsy and Behavior Reports	2021	7
39	Functional seizures are not less important than epilepsy	Epilepsy and Behavior Reports	2021	7
40	Extending the reach of science – Talk in plain language	Epilepsy and Behavior Reports	2021	7
41	Subjective versus objective measures of distress, arousal and symptom burden in patients with functional seizures and other functional neurological symptom disorder presentations: A systematic review	Epilepsy and Behavior Reports	2021	7
42	Neurostimulation for the treatment of functional neurological disorder: A systematic review	Epilepsy and Behavior Reports	2021	7
43	Effectiveness and safety of adjunctive cenobamate for focal seizures in adults with developmental disability treated in clinical practice	Epilepsy and Behavior Reports	2022	7
44	Acute liver failure in a military recruit treated with valproic acid and harboring a previously unrecognized POLG-1 mutation	Epilepsy and Behavior Reports	2019	6
45	No effect of electrical transcranial direct current stimulation adjunct treatment for epilepsia partialis continua in POLG disease	Epilepsy and Behavior Reports	2019	6
46	Addressing the epilepsy surgery gap: Impact of community/tertiary epilepsy center collaboration	Epilepsy and Behavior Reports	2020	6
47	Cortical and thalamic electrode implant followed by temporary continuous subthreshold stimulation yields long-term seizure freedom: A case report	Epilepsy and Behavior Reports	2020	6
48	Severe drug-induced liver injury caused by levetiracetam – A case report and review of the literature	Epilepsy and Behavior Reports	2021	6
49	Fenfluramine in the successful treatment of super-refractory status epilepticus in a patient with Dravet syndrome	Epilepsy and Behavior Reports	2021	6
50	Rapid development of seizures and PRES in a COVID-19 patient	Epilepsy and Behavior Reports	2021	6

Scientometrics

Overviews

Citing Bodies

Epilepsy and Behavior Reports

Top Articles